152 related articles for article (PubMed ID: 23136854)
1. Sulfatase inhibitors: a patent review.
Williams SJ
Expert Opin Ther Pat; 2013 Jan; 23(1):79-98. PubMed ID: 23136854
[TBL] [Abstract][Full Text] [Related]
2. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
3. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
4. Steroid sulfatase inhibitors: the current landscape.
Anbar HS; Isa Z; Elounais JJ; Jameel MA; Zib JH; Samer AM; Jawad AF; El-Gamal MI
Expert Opin Ther Pat; 2021 Jun; 31(6):453-472. PubMed ID: 33783295
[No Abstract] [Full Text] [Related]
5. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
Purohit A; Foster PA
J Endocrinol; 2012 Feb; 212(2):99-110. PubMed ID: 21859802
[TBL] [Abstract][Full Text] [Related]
6. Steroid derivatives as inhibitors of steroid sulfatase.
Mostafa YA; Taylor SD
J Steroid Biochem Mol Biol; 2013 Sep; 137():183-98. PubMed ID: 23391659
[TBL] [Abstract][Full Text] [Related]
7. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
[TBL] [Abstract][Full Text] [Related]
8. [Steroid sulfatase inhibitor].
Nakata T; Ishida H; Shiotsu Y
Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670
[TBL] [Abstract][Full Text] [Related]
10. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
11. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
[TBL] [Abstract][Full Text] [Related]
12. Steroid sulfatase inhibition success and limitation in breast cancer clinical assays: An underlying mechanism.
Sang X; Han H; Poirier D; Lin SX
J Steroid Biochem Mol Biol; 2018 Oct; 183():80-93. PubMed ID: 29803725
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulfatase inhibitors: promising new therapy for breast cancer.
Sadozai H
J Pak Med Assoc; 2013 Apr; 63(4):509-15. PubMed ID: 23905452
[TBL] [Abstract][Full Text] [Related]
15. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
17. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
18. Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Palmieri C; Januszewski A; Stanway S; Coombes RC
Expert Rev Anticancer Ther; 2011 Feb; 11(2):179-83. PubMed ID: 21342037
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase: molecular biology, regulation, and inhibition.
Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
[TBL] [Abstract][Full Text] [Related]
20. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
Geisler J; Sasano H; Chen S; Purohit A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]